Browse resources

Topic: Disease/vaccine specific information

Total results with these characteristics: 988

Page 3 of 40  
‹ prev.
1
2
3
4
5
6
next ›

Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid-CbpA Peptide Recombinant Fusion Protein

Pneumococcus, meningococcus and Haemophilus influenzae cause a similar spectrum of infections in the ear, lung, blood, and brain. They share cross-reactive antigens that bind to the laminin receptor of the blood-brain barrier as a molecular basis …

Author: Mann B, Thornton J, Heath R, et al.

Published: 2013

Burden and Aetiology of Diarrhoeal Disease in Infants and Young Children in Developing Countries (the Global Enteric Multicenter Study, GEMS): A Prospective, Case-Control Study

This article, published in The Lancet, reports on results of the Global Enteric Multicenter Study (GEMS), which was designed to identify the aetiology and population-based burden of pediatric diarrheal disease in sub-Saharan Africa and south Asia. …

Author: Kotloff KL, Nataro JP, Blackwelder WC, et al.

Published: 2013

Burden of Disease Caused by Streptococcus Pneumoniae in Children Younger than 5 Years: Global Estimates

This article, published in The Lancet, releases new global burden of disease data for Streptococcus pneumoniae (pneumococcus), a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide. The results also include data at the …

Author: O'Brien KL, Wolfson LJ, Watt JP, et al.

Published: 2009

The Burden of JE in Southeast Asia: The Role of NGOs in the Fight Against the Disease

This presentation, given at the 2006 meeting of the American Society for Tropical Medicine and Hygiene, provides an overview of JE disease burden and the activities of the PATH JE project.

Author: PATH

Published: 2006

Burden of Paediatric Rotavirus Gastroenteritis (RVGE) and Potential Benefits of a Universal Rotavirus Vaccination Programme with a Pentavalent Vaccine in Spain

This study, published in BMC Public Health, assesses the health outcomes and the economic impact of a universal rotavirus vaccination program with RotaTeq, a pentavalent rotavirus vaccine, against a no vaccination program in Spain. The study …

Author: Diez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M

Published: 2010

The Burden of Pneumococcal Disease Among Latin American and Caribbean Children: Review of the Evidence

This article, published in the Pan American Journal of Public Health, estimates the annual burden of pneumonia, meningitis, and acute otitis media caused by pneumococcus in children less than five years of age in Latin America and the …

Author: Valenzuela MT, O'Loughlin R, De La Hoz F, et al.

Published: 2009

The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

Author: Sabin Vaccine Institute

Published: 2007

Business and Cervical Cancer: Opportunities to Save Lives

This document is a five-page brief on cervical cancer prevention. It discusses the growing threat of human papillomavirus (HPV), early detection and screening, and available options for prevention and treatment. It also explores various …

Author: GBCHealth

Published: 2013

Calling the Shots: A Review of Global Immunisation Initiatives and Future Priorities

This report reviews the successes and challenges of current global immunization programs, with a particular focus on: pneumonia, diarrheal disease, polio, measles, and rubella. It argues that while there is much to be applauded, there is a funding …

Author: Royal College of Paediatrics and Child Health

Published: 2013

Cambodia: "Coverage Improvement Planning" Pays Off

This report discusses the work of PATH's Children's Vaccine Program and the Australian International Health Institute of the University of Melbourne to provide technical assistance with immunization programming to Cambodia, including the …

Author: PATH

Published: 2004

Can Successful Vaccines Teach Us How to Induce Efficient Protective Immune Responses?

This article, published in Nature Medicine, reviews current successful vaccines and identifies their mechanisms of protection in the hopes of tackling the challenges posed by those infectious targets that have thus far escaped successful …

Author: Lambert PH, Liu M, Siegrist CA

Published: 2005

Can We Defeat Meningococcal Disease in Low and Middle Income Countries?

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

Author: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Published: 2012

Can We, Should We, Eradicate the Meningococcus?

The authors of this article, published in Vaccine, discuss how the introduction of vaccines against Neisseria meningitidis raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even …

Author: Maiden MC, Frosch M

Published: 2012

Carriage of Neisseria Meningitidis in 2 - 29 Years Old in Mali, Senegal and The Gambia

This poster, presented at the 16th International Pathogenic Neisseria Conference in the Netherlands, discusses a study that aimed to provide preliminary information regarding meningococcal carriage in West Africa and on the effect on …

Author: Caugant DA, Tamboura B, Tapia M, et al.

Published: 2008

The Case for Investment in Enterotoxigenic Escherichia coli Vaccines

This market assessment aims to increase the awareness of biotechnology and pharmaceutical companies worldwide about the opportunities and potential markets that exist for low-cost and effective vaccines against enterotoxigenic Escherichia coli …

Author: PATH; BIO Ventures for Global Health

Published: 2011

Cervical Cancer Action: 2007 to 2014 . . . and Beyond

This briefing paper highlights Cervical Cancer Action's accomplishments and global milestones, engagements and country support, and plans for future investment. It includes a detailed timeline which spans from 2007 to 2013 and a map of the rapid …

Author: Cervical Cancer Action

Published: 2014

Cervical Cancer, Cervical Dysplasia, Genital Warts: The Pathogenesis and Clinical Outcomes of HPV Anogenital Infections

This technical six-minute animation explains what HPV is, shows how it infects human tissue, and how disease progresses. It also provides disease burden information specific to HPV and cervical cancer.

Author: Sanofi Pasteur MSD

Published: 2006

Cervical Cancer, Human Papillomavirus (HPV), and HPV vaccines: Key Points for Policy-Makers and Health Professionals

HPV vaccines address a critical public health need, and will be an important element of a comprehensive cervical cancer control strategy. Ensuring universal access to HPV vaccination, screening, and treatment services will be key to reducing the …

Author: World Health Organization

Published: 2008

Cervical Cancer Prevention Action Planner

This interactive tool is designed for public health officials seeking guidance and resources related to developing evidence-based cervical cancer prevention programs in their countries. It includes video mini-lectures and other films, impact models, …

Author: PATH

Published: 2012

Cervical Cancer Prevention and HPV Vaccines

This fact sheet outlines the types of support the GAVI Alliance offers for the introduction of human papillomavirus (HPV) vaccines in eligible countries. It also links to the specific requirements for country applications.

Author: GAVI Alliance

Published: 2014

Cervical Cancer Prevention and the Millennium Development Goals

This article, published in the Bulletin of the World Health Organization, explores how scaled-up cervical cancer prevention activities, including introduction of the new HPV vaccines and increased access to precancer screening and treatment, can …

Author: Wittet S, Tsu V

Published: 2008

Cervical Cancer Prevention at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers

This report describes PATH's key cervical cancer prevention initiatives, which include providing technical assistance with human papillomavirus (HPV) vaccine program strategy and planning to low- and middle-income countries.

Author: PATH

Published: 2013

Cervical Cancer Screening and Treatment in Low-Resource Settings: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report examines the …

Author: PATH

Published: 2013

Cervical Cancer: The Real Lady Killer

This film in the BBC’s "Kill or Cure?" series uncovers the challenges of preventing and treating cervical cancer in Africa and highlights exciting new opportunities for dramatically reducing the toll of disease. The BBC crew follows Sarah …

Author: PATH, Rockhopper Productions

Published: 2009

Challenges Faced by the Global Polio Eradication Initiative

After the World Health Assembly resolved in 1988 to eradicate wild poliovirus (WPV) transmission globally by 2000, dramatic progress in reducing polio cases and increasing the number of countries that interrupted indigenous WPV transmission was …

Author: Wassilak S, Orenstein W

Published: 2010

Page 3 of 40  
‹ prev.
1
2
3
4
5
6
next ›